Six readers
| reader | found | score |
|---|---|---|
| genetics Open Targets | no genetic evidence; overall 0.05 from other evidence | 0.00 |
| cell type Human Protein Atlas | cell type enhanced outside the brain (epicardial cells) | 0.10 |
| chemistry Open Targets | compounds already reach it: mepolizumab, reslizumab, depemokimab | 0.90 |
| trials ClinicalTrials.gov | 4 Parkinson's trials, 1 stopped | 0.80 |
| literature PubMed | 14 Parkinson's papers of 18,173 | 0.64 |
| pathways Reactome | 4 pathways; mostly immune signalling | 0.90 |
No case: the score is under the bar. Receipt 5442
Sealed predictions
- IL5 in dopamine neurons, braakn/a → n/areceipt 5449
Swarm cases
receipt 5449: IL5 in dopamine neurons, braak
- cell type
- IL5 is not measured in dopamine neurons; looking elsewhere.
- cell type
- no other cell group does better.
- axis
- no measure beats "tracks Braak Lewy-body stage" for IL5 in dopamine neurons.
case closed: nothing better to follow up.
Receipts
loading the receipts